AzTrials
AzTrials

Pregnancy RelatedNCT05341921

Deep Breathing Techniques (Pranayama) in Pregnancy

A study testing Alternate Nostril Breathing, Bhramari Breathing and Sheetali Breathing in people with Pregnancy Related and Hypertension in Pregnancy, run by Children's Mercy Hospital Kansas City at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Slow deep breathing actives the vagal nerve and leads to a natural reduction in physiological parameters such as blood pressure, heart rate and digestion. The effects of these techniques have not been assessed in pregnancy. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
What is being tested?
Alternate Nostril Breathing, Bhramari Breathing and Sheetali Breathing
Could I receive a placebo?
No, everyone receives an active treatment
How many people
62 participants
Where
1 siteUnited States
Study dates
2 Aug 2022to 31 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Any pregnant woman in the 3rd trimester after 28 weeks of pregnancy who is/has
  • 18 years of age or older
  • English speaking
  • Phase II Only- Chronic hypertension - defined as pre-existing elevated blood pressure prior to pregnancy or less than 20 weeks gestation (Systolic blood pressure greater than or equal to 140 mmHg and /or a diastolic blood pressure greater than or equal to 90 mmHg) with or without antihypertensive use
  • Phase II Only- Gestational hypertension - defined as elevated blood pressure (Systolic blood pressure greater than or equal to 140 mmHg and /or a diastolic blood pressure greater than or equal to 90 mmHg) after 20 weeks of pregnancy without any evidence of end-organ damage or proteinuria, with or without antihypertensive use
  • Phase II Only- Preeclampsia without severe features - defined as elevated blood pressure (Systolic blood pressure greater than or equal to 140 mmHg but less than 160 mmHG and /or a diastolic blood pressure greater than or equal to 90 mmHg but less than 110 mmHg on two or more occasions 4 hours or more apart) with evidence of proteinuria, with or without antihypertensive use

Who cannot join

  • Any unstable maternal or fetal condition that requires urgent delivery
  • Any concerns for pre-eclampsia with or without severe features (i.e. Development of HELLP syndrome or eclampsia)
  • Severe pulmonary disease
  • Active or acute pulmonary disease
  • Known deviated nasal septum
  • Does not desire to perform breath-controlled exercises
Show all 9Show fewer
  • Low blood pressure defined as baseline blood pressure less or equal to a systolic of 90 mmHg and/or a diastolic blood pressure of 60 mmHg
  • Cannot roll their tongue
  • Have difficulty or cannot breathe through their nose

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Advent Health Shawnee Mission Birth Center

    Merriam, Kansas, 66204

Other trials in United States

About this study

Official title: The Acute Effects of Pranayama (Deep Breathing Techniques) on Physiological Parameters in Pregnancy

Slow deep breathing actives the vagal nerve and leads to a natural reduction in physiological parameters such as blood pressure, heart rate and digestion. The effects of these techniques have not been assessed in pregnancy. The primary objective is to assess the effects of various yogic deep breathing techniques on blood pressure during pregnancy. The breathing exercises will include Alternate nostril breathing, Bhramari breathing, and Sheetali breathing. A secondary objective will be to assess the effects of these breathing exercises on other physiological parameters including heart rate, heart rate variability, body temperature, cardiac output, vascular resistance and respiratory rate.

Read the detailed description

The trial will be conducted as a pilot study in one study visit, which will be conducted in two phases. Phase I will be conducted on normotensive pregnant women and Phase II will be conducted on hypertensive pregnant women. Participants will be in their third trimester of pregnancy (28 weeks onwards).

Upon presentation, they will be randomized into one of three groups: Alternate nostril breathing, Bhramari breathing or Sheetali breathing. Maternal monitoring devices will be placed on the patient before the intervention. The fetus will be monitored by external monitors consisting of a fetal heart rate monitor and tocodynamometer to assess uterine activity. Fetal position will be assessed before and after the intervention by ultrasound. All devices will obtain a reading for 15 minutes before, during and after the intervention.

Intervention: In an upright, seated position, the participant will engage in a total of 15 minutes of one deep breathing technique. The breathing practice will be conducted in three, 5-minute increments with a one-minute break between each session. These breathing techniques are easy to learn and participants will be taught how to perform the exercise (visual demonstration, verbal and written instructions will be provided). Participants will be given the opportunity to practice the breathing technique and ask any questions prior to initiating monitoring.

Being tested
Alternate Nostril Breathing, Bhramari Breathing, Sheetali Breathing
Medical subject headings
Hypertension, Pregnancy-Induced

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Alternate Nostril BreathingBehavioural

    Utilizing Pranayama (deep breathing technique) in normotensive and hypertensive women in 3rd trimester of pregnancy

  • Bhramari BreathingBehavioural

    Utilizing Pranayama (deep breathing technique) in normotensive and hypertensive women in 3rd trimester of pregnancy

  • Sheetali BreathingBehavioural

    Utilizing Pranayama (deep breathing technique) in normotensive and hypertensive women in 3rd trimester of pregnancy

Study groups in NCT05341921
Study groupRoleWhat they receive
Alternate Nostril Breathing Phase IActive comparatorAlternate nostril breathing for normotensive women in 3rd trimester of pregnancy
Receives: Behavioral: Alternate Nostril Breathing
Bhramari Breathing Phase IActive comparatorBhramari breathing for normotensive women in 3rd trimester of pregnancy
Receives: Behavioral: Bhramari Breathing
Sheetali Breathing Phase IActive comparatorSheetali breathing for normotensive women in 3rd trimester of pregnancy
Receives: Behavioral: Sheetali Breathing
Alternate Nostril Breathing Phase IIActive comparatorAlternate nostril breathing for hypertensive women in 3rd trimester of pregnancy
Receives: Behavioral: Alternate Nostril Breathing
Bhramari Breathing Phase IIActive comparatorBhramari breathing for hypertensive women in 3rd trimester of pregnancy
Receives: Behavioral: Bhramari Breathing
Sheetali Breathing Phase IIActive comparatorSheetali breathing for hypertensive women in 3rd trimester of pregnancy
Receives: Behavioral: Sheetali Breathing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of blood pressure from baseline in normotensive and hypertensive women in 3rd trimester pregnancy while utilizing various pranayama breathing techniques

    Continuous blood pressure monitored while participants engage in a deep breathing technique (pranayama breathing)

    Measured: One visit, 15 minute intervention

Secondary outcomes (3)
  1. Change of heart rate from baseline to after the intervention

    Continuous heart rate monitor will be applied

    Measured: One visit, 15 minute intervention

  2. Change in body temperature from baseline to after the intervention

    Continuous temperature monitor will be applied

    Measured: One visit, 15 minute intervention

  3. Change in cardiac output from baseline to after the intervention

    Continuous cardiac output monitor will be applied

    Measured: One visit, 15 minute intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Apr 2022
  2. Study start2 Aug 2022
  3. Primary completion31 Dec 2024
  4. Study completion31 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Pilot, randomized, controlled trial
Masking
None (open label)
Enrolment
62 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05341921
Sponsor's protocol ID
STUDY00002180
Status last verified
Apr 2025
First submitted
18 Apr 2022
Last updated
20 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Alternate Nostril Breathing, Bhramari Breathing and Sheetali Breathing in people with Pregnancy Related and Hypertension in Pregnancy, run by Children's Mercy Hospital Kansas City at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of blood pressure from baseline in normotensive and hypertensive women in 3rd trimester pregnancy while utilizing various pranayama breathing techniques (time frame: One visit, 15 minute intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Apr 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in